Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Cisplatin, and Liposomal Doxorubicin in Stage III Ovarian Cancer
NCT00003896Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 1999
- Primary completion
- Feb 2008
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin, pegylated liposomal doxorubicin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by SWOG Cancer Research Network. Started Sep 1999; status: completed.
02
Drugs
paclitaxelcisplatinpegylated liposomal doxorubicin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00003896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003896.